Episode 213 - Fred Aslan - CEO Artiva Bio episode artwork

EPISODE · Aug 7, 2026 · 29 MIN

Episode 213 - Fred Aslan - CEO Artiva Bio

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

In this episode of The BioHub by Avetix, I’m joined by Fred Aslan, President and CEO of Artiva Biotherapeutics.Fred shares his journey across venture capital, business development and biotech leadership, including his time at Venrock and Vividion, and how those experiences shaped the way he now leads Artiva.We discuss what it takes to build and scale a biotech, how investor experience changes the way you make decisions as a CEO, the opportunity for off-the-shelf cell therapies, and where Fred sees the future of the cell therapy space heading.

Episode metadata supplied by the publisher feed · Published Aug 7, 2026

Embed this episode

NOW PLAYING

Episode 213 - Fred Aslan - CEO Artiva Bio

0:00 29:12

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 29 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on August 7, 2026.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!